Robert D Henderson,* Pamela A McCombe*
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Royal Brisbane and Women’s Hospital, Herston Road, Herston, QLD 4029.
Correspondence: Robert_Henderson@health.qld.gov.au
- 1. Kiernan MC. Riluzole: a glimmer of hope in the treatment of motor neurone disease. Med J Aust 2005; 182: 319-320. <MJA full text>
- 2. Remy A-J, Camu W, Ramos J, et al. Acute hepatitis after riluzole administration. J Hepatol 1999; 30: 527-530.
- 3. Sax DS, Kornetsky C, Kim A. Lack of hepatotoxicity with naltrexone treatment. J Clin Pharmacol 1994; 34: 898-901.
- 4. Porter SJ, Somogyi AA, White JM. Kinetics and inhibition of the formation of 6β-naltrexol from naltrexone in human liver cytosol. Br J Clin Pharmacol 2000 50; 465-471.
Online responses are no longer available. Please refer to our instructions for authors page for more information.